Jessica Presa, MD (she/her/hers)

Senior Director
Pfizer, Inc.

Disclosure(s): Pfizer Inc: Industry, Stocks/Bonds (Public Company)

Medical Doctor degree from FAMEMA/Marilia-SP/Brazil in 1995. Pediatrician from Hospital Infantil Candido Fountoura/Sao Paulo/Brazil and neonatologist from Hospital e Maternidade Leonor Mendes de Barros/Sao Paulo/Brazil. Master in Science in Pharmacoeconomics and Vaccines from Santa Casa de Misericordia de Sao Paulo/Brazil in 2012. Experience of 25 years working in the vaccine field, lately with a focus on meningococcal vaccines. 18 years working for Pfizer Vaccines.

Poster(s):

• (P-564) Ten-year Retrospective Review of Medical Records at Five Hospitals in the United States Highlights the Potential for Under-detection of Invasive Meningococcal Disease
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-570) Need for Broad Protection Against Invasive Meningococcal Disease Among US College Students
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1458) Awareness, Attitudes and Perceptions of Meningococcal Vaccines among Caregivers of Adolescents in the United States
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1459) Utility of the Pentavalent MenABCWY Meningococcal Vaccine (PenbrayaTM) Within Alternative US Meningococcal Vaccination Schedules
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET